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ORIGINAL ARTICLE
Adaptive changes in the neuronal proteome: mitochondrial energy
production, endoplasmic reticulum stress, and ribosomal
dysfunction in the cellular response to metabolic stress
Abigail G Herrmann1, Ruth F Deighton1, Thierry Le Bihan2,3, Mailis C McCulloch4, James L Searcy1, Lorraine E Kerr2 and
James McCulloch1
Impaired energy metabolism in neurons is integral to a range of neurodegenerative diseases, from Alzheimer’s disease to stroke.
To investigate the complex molecular changes underpinning cellular adaptation to metabolic stress, we have deﬁned the
proteomic response of the SH-SY5Y human neuroblastoma cell line after exposure to a metabolic challenge of oxygen glucose
deprivation (OGD) in vitro. A total of 958 proteins across multiple subcellular compartments were detected and quantiﬁed by
label-free liquid chromatography mass spectrometry. The levels of 130 proteins were signiﬁcantly increased (Po0.01) after OGD
and the levels of 63 proteins were signiﬁcantly decreased (Po0.01) while expression of the majority of proteins (765) was not
altered. Network analysis identiﬁed novel protein–protein interactomes involved with mitochondrial energy production, protein
folding, and protein degradation, indicative of coherent and integrated proteomic responses to the metabolic challenge.
Approximately one third (61) of the differentially expressed proteins was associated with the endoplasmic reticulum and
mitochondria. Electron microscopic analysis of these subcellular structures showed morphologic changes consistent with the
identiﬁed proteomic alterations. Our investigation of the global cellular response to a metabolic challenge clearly shows the
considerable adaptive capacity of the proteome to a slowly evolving metabolic challenge.
Journal of Cerebral Blood Flow & Metabolism (2013) 33, 673–683; doi:10.1038/jcbfm.2012.204; published online 16 January 2013
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INTRODUCTION
Impaired energy metabolism in neurons is integral to many
central nervous system diseases. An acute, intense metabolic
challenge during conditions such as stroke and brain trauma can
induce irreversible neuronal damage.1 By contrast, age-related
chronic metabolic impairment is thought to contribute to the
evolution of neurodegenerative diseases such as Alzheimer’s
disease, Parkinson’s disease, and Huntington’s disease.2,3
Neurochemical cascades initiated by both acute and prolonged
metabolic challenges can induce cell death via an elevation of
proapoptotic proteins. These metabolic challenges can also
activate genomic and proteomic responses promoting cell
survival in the immediate phase as well as preparing the cell to
deal with similar challenges in the future (conditioning).4
Subcellular organelles display complex proteomic responses to
impaired energy metabolism, with these responses ultimately
determining the death or survival of the cell. In mitochondria,
metabolic stress can disrupt energy generation, provoke mito-
chondrial swelling, and initiate apoptosis, all with potentially lethal
consequences.5 In response to cell stress, the endoplasmic
reticulum (ER) detects and reconﬁgures misfolded proteins in a
process known as the unfolded protein response (UPR). The UPR is
integral to cell survival as excessive accumulation of these
damaged proteins in the ER lumen can result in the suppression
of protein synthesis and irreversible pathology.6 In the nucleus
and ribosomes, metabolic stress leads to a genomic response and
the synthesis of proteins such as heat-shock proteins and trophic
factors, which contribute to protein repair and neuronal survival.7
The genomic response to metabolic challenge has been well
characterized both in vitro and in vivo.8–10 In the present study, we
provide a comprehensive cellular proteomic response and explore
the extent to which proteins are altered after a metabolic
challenge.
Oxygen glucose deprivation (OGD) induces metabolic stress in
neurons in culture.11,12 The intensity of the metabolic challenge
can be controlled by adjusting experimental conditions such as
the choice of cell line and alterations in the duration of OGD. Mass
spectrometry-based proteomics provides an excellent platform to
quantify OGD-dependent protein changes and to gain a fresh
perspective on adaptations that occur within the proteome in
response to metabolic stress.13 We have used human SH-SY5Y
neuroblastoma cells and label-free liquid chromatography mass
spectrometry (LC-MS) to deﬁne the integrated proteomic response
to metabolic stress that induces severe mitochondrial dysfunction
but only limited cell death. The majority of proteins analyzed
(800 out of 1,000) were not signiﬁcantly altered by OGD.
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Protein increases after OGD was more than twice as frequent as
was decreases, consistent with an integrated cellular survival
response. Protein interactomes highlight coordinated proteomic
responses after OGD in relation to mitochondrial energy
production, ER stress, and ribosomal dysfunction.
MATERIALS AND METHODS
Reagents
All standard growth media used was obtained from Invitrogen (Paisley,
UK), unless otherwise stated, and all procedures were conducted in
compliance with all relevant legislation in the United Kingdom. Cells were
routinely maintained in standard 75 cm2 cell culture-treated ﬂasks (Greiner
Bio One, Stonehouse, UK) within a continuous ﬂow incubator at 371C, with
5% CO2 in fully humidiﬁed air. All growth media and solutions were
prewarmed to 371C before contact with cells, unless otherwise stated. The
acetonitrile and water used in the LC-MS buffer solutions were of HPLC
grade (Fisher, Loughborough, UK). Formic acid was of 98% to 100% purity
(Merck, Darmstadt, Germany) and triﬂuoroacetic acid was 99% sequencing
grade (Sigma-Aldrich, Gillingham, UK). All other chemicals used in the
processing of the protein samples were of reagent grade or better. The
trypsin used for protein digestion was from Promega (Southampton, UK).
Cell Culture and Oxygen Glucose Deprivation
SH-SY5Y cells (ATCC, Manassas, VA, USA) were cultured in Dulbecco’s
Modiﬁed Eagle Medium: Nutrient Mixture F12 (DMEM/F12) supplemented
with 2mmol/L L-Glutamine, 100U/mL Penicillin, 100mg/mL Streptomycin,
and fetal bovine serum. Cells were routinely maintained at 371C, 5% CO2,
with culture medium replaced biweekly. Oxygen glucose deprivation (for 3,
6, 9, 12, and 18 hour durations) was achieved through incubation of the
cells at 371C in 95% N2:5% CO2. Aglycemia was induced by replacing
standard culture medium with glucose-free DMEM supplemented with
fetal bovine serum, after a glucose-free wash step. Control cells underwent
the same glucose-free wash step, followed by incubation with glucose
containing media (4,500mg/L glucose). The osmolality of the DMEM
solutions used was within the range of 300 to 340mOsm/kg for the no
glucose solutions, and 320 to 360mOsm/kg for the glucose containing
media. All media were equilibrated overnight before experimentation in
either normoxic or anoxic chambers. Oxygen content in the media was
recorded in preliminary studies using a ﬁber optic dual oxygen-temperature
sensing probe (OxyLite 2000 E Series, Oxford Optronix, Oxford, UK). A rapid
oxygen depletion phase was recorded, with oxygen partial pressure falling
exponentially from 140 to 7mmHg over the initial 3 hours of OGD. Oxygen
depletion plateaued and remained severely hypoxic between 4 and 18hours
with a recorded average partial pressure of 2mmHg.
Assessment of Mitochondrial Function (MTS Assay)
Cells were seeded onto poly-D-lysine coated ﬂat-bottomed 96-well plates
at a density of 125,000 cells per well overnight. After OGD, glucose-free
DMEM was replaced with 200mL glucose-containing DMEM and cell
viability was assessed using 20 mL of CellTiter 96 AQueous One Solution
Cell Proliferation Assay (MTS) (Promega, Madison, USA) as per the
manufacturer’s guidelines. Cells were incubated for 2 hours in glucose
containing, normoxic media (371C, 5% CO2) to allow residual mitochondrial
function after OGD to be assessed using a Dynex MRX plate reader (Dynex
Technologies Ltd., Worthing, UK) at 490l.
Assessment of Global Cell Death (Trypan Blue)
Trypan blue staining was carried out to assess the extent of cell death
occurring after each OGD time point. Cells were collected immediately
at the end of each time point by trypsinization, centrifugation (200 g,
7minutes) and resuspension in glucose-containing DMEM. Cells were
incubated with 0.1% trypan blue as per the manufacturer’s instructions
(Invitrogen). A hemocytometer was used to count stained and unstained
cells. The percentage of stained cells in each OGD and time-matched
control sample was calculated.
Preparation of Protein Samples for Liquid-Chromatography
Mass Spectrometry
SH-SY5Y cells were treated with 6 hours OGD (n¼ 6 independent samples
per group) and 18 hours OGD (n¼ 6), with a time-matched control for each
sample. After OGD or ‘control’ incubations, SH-SY5Y cells were immediately
scraped and centrifuged (200 g, 7minutes). Cell pellets were washed in
Hanks Buffered Saline Solution and recentrifuged. Washed cell pellets were
resuspended in 1ml Hanks Buffered Saline Solution and centrifuged
(6,000 g, 3minutes). Supernatants were removed and the pellets snap
frozen for temporary storage at  801C. Cell pellets were defrosted and
lysed in 100mL 8M urea using a cordless motor pellet pestle (Sigma-
Aldrich, Dorset, UK). Samples were then centrifuged (14,000 g, 15minutes)
and supernatants recovered. Total protein content was determined using
the Pierce BCA Protein Assay Kit (Thermo-Fisher, Loughborough, UK).
Protein extract (140mg) from OGD and control samples were digested as
previously described.14
Liquid Chromatography Mass Spectrometry
Label-free intensity-based LC-MS was used to identify proteins differen-
tially expressed after 6 and 18 hours OGD relative to time-matched
controls. Capillary LC-MS data were acquired on an online system
consisting of a micro-pump (1200 binary HPLC system, Agilent, Edinburgh,
UK) coupled to a hybrid LTQ-Orbitrap XL instrument controlled through
Xcalibur 2.0.7 (Thermo-Fisher). Peptides were reconstituted in 20 mL of
loading buffer before injection and 8 mL was loaded. The HPLC separation
was provided by a gradient between buffer A (97.5% H2O, 2.5%
acetonitrile, 0.1% formic acid) and buffer B (90% acetonitrile, 10% H2O,
0.025% triﬂuoroacetic acid, 0.1% formic acid). The peptide mixture was
separated on a 140-minute gradient. The mass spectrometer was operated
in ‘data-dependent mode’, with a single MS scan (400 to 2,000 m/z)
followed by MS/MS scans in the linear ion trap on the ﬁve most abundant
ions and excluded for 120 seconds.
Protein Identiﬁcation and Quantiﬁcation
All LC-MS runs were analyzed using a label-free intensity-based approach
with Progenesis (version 4.0 Nonlinear Dynamics, Newcastle, UK), under
randomized conditions. The MS/MS data were searched using MASCOT
versions 2.3 (Matrix Science Ltd, London, UK) against a human subset of
the NCBI database (downloaded on 12 January 2011) with 34,281
sequences using a maximum missed-cut of 2. Variable methionine
oxidation, STY phosphorylation, protein N-terminal acetylation, and ﬁxed
cysteine carbamidomethylation were used in all searches.
LC-MS label-free quantiﬁcation was performed using Progenesis 4.0
(Nonlinear Dynamics). Protein conﬂict (peptides shared between different
proteins) was solved as followed: conﬂict resulting from multiple sequence
assignment to the same peak; we kept only the sequence having the
highest score. Conﬂict resulting from same peptide sequences assigned to
different proteins, the assignment was singly attributed to the protein that
had the highest number of peptides. Regarding the label-free quantitation,
the total number of Features (i.e., intensity signal at a given retention time
and m/z) was reduced to MSMS peaks with charge of 2, 3, or 4þ and we
only kept the ﬁve most intense MSMS spectra per ‘Feature’. The subset of
multicharged ions (2þ , 3þ , and 4þ ) was extracted from each LC-MS run
and the ions intensities summed for normalization. Protein quantitation
was performed as follows; for a speciﬁc protein, the associated unique
peptide ions were summed to generate an abundance value. The
measured protein abundances were transformed using an ArcSinH
function (as the method of detection can generate a signiﬁcant amount
of near zero measurement for which a log transform is not ideal). The
within-group means were calculated to determine the fold change and the
transformed data were then used to calculate the P values using one-way
analysis of variance. Signiﬁcant changes in protein expression (Po0.01)
between control and OGD experimental groups were determined for each
time point (6 and 18 hours) using Student’s t-test.
Analysis of Protein Subcellular Localization
All 958 proteins identiﬁed by LC-MS by at least two or more peptides were
uploaded to the Database for Annotation, Visualization and Integrated
Discovery (DAVID) (http://david.abcc.ncifcrf.gov15) to determine subcellular
localization based on gene ontology (GO). Protein clusters founded on
subcellular localization with DAVID scores 42 were used. Proteins
signiﬁcantly altered (Po0.01) after 18 hours OGD were also assessed by
DAVID according to subcellular localization.
Interactome Analysis of Proteins Altered with Oxygen Glucose
Deprivation
Protein identiﬁers of all the proteins signiﬁcantly altered after 18 hours
OGD (Po0.01) were uploaded with their corresponding fold change values
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to Ingenuity Pathway Analysis software (IPA; http://www.ingenuity.com).
Interactomes were algorithmically generated based on direct relationships
(physical interactions and associations) between eligible proteins.
The interactomes are color coded with green nodes representing proteins
that were downregulated after 18 hours OGD and red protein nodes
representing proteins that were upregulated after 18 hours OGD. The
shading of the interactome nodes is positively correlated with the
magnitude of fold change. The IPA generates a score for each interactome,
which is a putative measure of probability (see Deighton et al16 for critical
analysis).
Subcellular Morphology with Electron Microscopy
SH-SY5Y cells were exposed to OGD using the same paradigm as the LC-
MS study. Samples were collected immediately after 3, 9, and 18 hours of
OGD and ﬁxed for a minimum of 20 hours in aldehyde ﬁxative (4%
paraformaldehyde and 5% glutaradehyde in 0.08M sodium cacodylate
buffer, pH 7.2). Once ﬁxed, cells were centrifuged at 100 g, the supernatant
removed and replaced with a 3% solution of agar (type VII, low gelling
temperature; Sigma-Aldrich, Gillingham, UK). The gels were set at 41C for
5minutes before being cut into 1mm3 blocks and processed for electron
microscopy (EM). Processing, embedding, and staining were performed, as
described previously.17 Brieﬂy, the blocks were cut into 70 nm thick
sections, collected on 300 mesh copper grids, stained with Reynold’s lead
citrate and contrasted with uranyl acetate.
The EM sections were evaluated on a JEOL CX-100 II transmission
electron microscope (Tokyo, Japan). The evaluator was blinded to the
treatment condition of all samples. Cells were chosen from grid squares in
a predetermined pattern. Fifty cells were assessed from each treatment.
For each cell, the condition of mitochondria and rough ER was assessed.
Mitochondria were graded as ‘normal’ (cristae clearly visible across 450%
of the matrix), ‘swollen’ (with a proportion of the matrix lost) and ‘abnormal’
(with most/ the entire matrix lost). The ER in each cell was graded similarly,
i.e., ‘normal’ (where ER outer membranes ran parallel to each other),
‘swollen’ (where modest swelling of ER outer membrane was present), or
‘abnormal’ where ER displayed extensive membrane swelling and
distortions. A Chi-Squared 3 2 matrix was used to test the null hypothesis
that OGD would have no effect on the ultrastructure of organelles.
RESULTS
Mitochondrial Function, Cell Viability, and Ultrastructure after
Oxygen Glucose Deprivation
Normal mitochondrial function was signiﬁcantly reduced in
SH-SY5Y cells after OGD relative to time-matched control cells
(Po0.0001, at each time point analyzed), with longer durations of
OGD inducing more severe mitochondrial dysfunction (Figure 1A).
Viability of SH-SY5Y cells treated with OGD was quantiﬁed using
Trypan Blue staining (Figure 1B). Minimal cell death was detected
after OGD, with 91% of cells remaining viable after 18 hours OGD.
Ultrastructural morphologic changes in subcellular organelles
were analyzed relative to time-matched controls by EM after OGD.
With increasing OGD duration, the number of cells displaying
abnormal ER was signiﬁcantly increased (Chi-Square, Po0.01)
(Figures 2A and 2C). SH-SY5Y cells also showed changes
in mitochondrial morphology with increasing OGD duration
(Figures 2B and 2D). It should be noted that even after 18 hours
OGD exposure, only 26% of cells displayed abnormal ER, and only
34% had abnormal mitochondria.
Global Proteomic Response after Oxygen Glucose Deprivation
(6 and 18 hours)
A total of 958 proteins were identiﬁed across all samples with two
or more peptides by LC-MS (Supplementary Table 1). Minimal
protein changes were observed after 6 hours OGD, with only 14
proteins signiﬁcantly altered in expression level (Po0.01). After
18 hours OGD, 193 proteins were signiﬁcantly altered in expres-
sion level (Po0.01) with 130 proteins increased and 63 proteins
decreased. For 765 proteins, no signiﬁcant difference was
observed between control and OGD samples after 18 hours OGD.
Subcellular distribution of all the 958 proteins identiﬁed by
LC-MS was examined using DAVID software. Proteins were
detected from across many subcellular compartments, including
the nuclear lumen, cytoskeleton, mitochondria, ER, golgi appara-
tus, ribosomes, and vesicles (Figure 3A).
The ascribed subcellular locations of the signiﬁcantly altered
proteins with OGD (18 hours) indicate that organelles are not
uniformly affected by the metabolic challenge. None of the
197 detected nuclear lumen proteins were signiﬁcantly altered
after OGD, while 41% of the 56 detected ER proteins and 32% of
the 118 detected mitochondrial proteins were signiﬁcantly altered
(Figure 3B). The signiﬁcantly increased and decreased proteins
after OGD (18 hours) are listed by subcellular location in Table 1
and Table 2, respectively.
Functional protein–protein interactions for the 193 proteins
altered with 18 hours OGD were deﬁned using IPA software.
IPA-generated 10 protein interactomes (Supplementary Table 2)
and three high-scoring interactomes (IPA scores 440) are
discussed in context below. These interactomes highlight a shift
in mitochondrial energy production, enhanced ER stress, and
ribosomal dysfunction.
Mitochondrial Protein Alterations after Oxygen Glucose
Deprivation (18 hours)
In all, 38 mitochondrial proteins (out of 118 detected; assigned
using the GO term mitochondrion GO:0005739) were signiﬁcantly
Figure 1. Mitochondrial function decreases after oxygen glucose deprivation (OGD), whereas cell viability is largely maintained.
(A) Mitochondrial function is significantly decreased at each OGD time point compared with time-matched controls. Mitochondrial function
was assessed using an MTS assay, with data presented as mean±s.d., n¼ 8 for each time point. (B) Cell viability is maintained up to 12 hours
OGD, with an increase in cell death after 18 hours OGD. Cell viability was assessed using a trypan blue dye exclusion assay. Data are presented
as mean±s.d., n¼ 3 for each time point. All data are expressed as a percentage of contemporaneous time matched controls (*Po0.05,
***Po0.0001, T-test).
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altered after OGD (18 hours): 29 were increased and 9 were
decreased. VDAC1 and TOM22, proteins involved in mediating the
movement of metabolites across the mitochondrial membrane,
were signiﬁcantly reduced after OGD. UQCRC1 and UQCRC2,
integral components of complex III of the electron transport chain
(ETC), were also signiﬁcantly reduced (Figure 4A). Coordinated
changes in other regions of the ETC were observed after 18 hours
OGD treatment: ETC complex V proteins ATP5J and ATP5A1, and
ETC complex I proteins NDUFS3 and NDUFA5 were all signiﬁcantly
increased (Po0.01).
Numerous mitochondrial proteins that have a role in lipid
metabolism were also found to be altered after 18 hours OGD.
ACADM, the enzyme involved in the ﬁrst step of fatty acid
beta oxidation was signiﬁcantly decreased (Po0.01); and
ECH1, HSD17B10 and ACAA2, enzymes downstream in the
beta-oxidation process were signiﬁcantly increased. ACAT1, a
mitochondrial protein involved in ketone metabolism was also
signiﬁcantly increased.
The highest scoring protein interactome generated by IPA
features some of the alterations in energy production described
above, namely increases in Complex V proteins (including ATP5J
and ATP5A1) and decreases in Complex III proteins (UQCRC1 and
UQCRC2) (Figure 4B). This Energy Production Interactome also
highlights interactions between altered components of the ETC
and other cellular machinery. Both UQCRC1 and UQCRC2 interact
with RTN4, a protein predominantly associated with regulating ER
function that was signiﬁcantly upregulated after OGD (Figure 4A).
UQCRC2 is also shown to interact with upregulated RUVBL2, a
cytoskeletal protein involved in numerous cellular activities
including transcription and cellular transformation (Figure 4A).
The Energy Production Interactome also contains a cluster
of ribosomal proteins that are distinct but intersect with the
ribosomal interactome described below.
Endoplasmic Reticulum Protein Alterations after Oxygen Glucose
Deprivation (18 hours)
In all, 23 ER proteins (out of 56 detected; assigned using the GO
term Endoplasmic reticulum GO:0005783) were signiﬁcantly altered
after 18 hours OGD: 19 were increased and 4 were decreased. A
number of proteins centrally involved in the UPR were signiﬁ-
cantly increased, including, HSPA5, HSP90B1, PDIA3, and PDIA4
(Po0.01) (Figure 5A). Other proteins including CALR, UGGT1,
ERP29, ERP44, and VCP that are integral to ER stress response and
protein folding were signiﬁcantly increased.
Multiple proteins that have a role in protein degradation were
signiﬁcantly altered after OGD (18 hours). Protein subunits of the
20S and 19S core structures of the 26S proteasome (PSMA5,
PSMC3, PSMC4, PSMD1, PSMD2, PSMD6, and PSMD11) were
increased. These proteasomal proteins, along with proteins
involved in the UPR and heat-shock response after OGD dominate
the high scoring, Protein Folding and Degradation Interactome
generated by IPA (Figure 5B).
Ribosomal Protein Alterations after Oxygen Glucose Deprivation
(18 hours)
In all, 11 ribosomal proteins (out of 82 detected; assigned using
the GO term Ribosome GO:0005840) were signiﬁcantly altered
after 18 hours OGD: 1 was increased and 10 were decreased.
The decreased ribosomal proteins were associated with both the
60S (RPL38, RPL23, RPL35, and RPL13) and 40S (RPS1, RPS14,
RPS23, RPS9, and RPS17) ribosomal subunits (Figure 5C). These
downregulated ribosomal proteins feature prominently in another
of the high scoring protein interactomes generated by IPA
(Figure 5D). An additionally important feature of this Ribosomal
Interactome is the cluster of upregulated peroxidases (PRDX1,
PRDX2, and PRDX5) (Figure 5C) involved in redox homeostasis and
Figure 2. The endoplasmic reticulum (ER) and mitochondria display progressive morphologic changes after oxygen glucose deprivation
(OGD). (A) OGD induced increases in the number of cells containing swollen and abnormal ER. Significant changes in the distribution of
‘normal’, ‘swollen’, and ‘abnormal’ ER within cells were seen after 3, 9, and 18 hours OGD compared with the time-matched controls (*Po0.05,
**Po0.01, w2). (B) The occurrence of mitochondrial morphologic abnormality increases after longer OGD durations. (C) Representative
electron micrographs of the three grades of ER morphology. Scale bar¼ 0.1 mm. (D) Representative electron micrographs of the three grades
of mitochondrial morphology. Scale bar¼ 0.1mm.
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protecting neurons from oxidative insults (for a review, see
Bell and Hardingham, 201118).
DISCUSSION
This study provides the ﬁrst comprehensive analysis of the
proteomic and morphologic response of human SH-SY5Y cells to
prolonged metabolic challenge. The robustness of SH-SY5Y cells
to external stressors has allowed the evolving proteomic changes
occurring in response to OGD induced metabolic stress to be
deﬁned, in the absence of cell death. The observed protein
changes provide insight into the complex molecular alterations
underpinning cellular adaptation to metabolic stress. The lack of
acute ischemic cell death in our in vitro model of neuronal
Figure 3. Subcellular distribution of detected proteins contrasted with subcellular distribution of proteins significantly altered after oxygen
glucose deprivation (OGD). Proteins were ascribed to subcellular compartment by DAVID software based on gene ontology. Proteins were
significantly altered after OGD (Po0.01) relative to their original levels in time-matched control samples. (A) Liquid chromatography mass
spectrometry (LC-MS) detected 958 proteins from across many subcellular compartments, showing the utility of LC-MS in providing a global
overview of cellular proteomics. (B) Organelles are differentially affected by 18 hours OGD. The 193 significant proteins changed (Po0.01)
were not distributed evenly across subcellular compartments: the endoplasmic reticulum and the mitochondria contained the largest
proportion of significantly altered proteins, whereas no significant protein changes were detected in the golgi apparatus or nuclear pore.
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Table 1. Proteins significantly increased with OGD (18hours)
Uniprot accn no. Gene name Protein name P value Fold change Protein function
Mitochondria
P30048 PRDX3 Peroxiredoxin III 0.0006 1.57 Cell redox homeostasis
P61604 HSPE1 10 kDa heat-shock protein 6.1E-06 1.51 Stress response
P18859 ATP5J ATP synthase-coupling factor 6 0.0016 1.44 ETC complex V
O75489 NDUFS3 NADH-ubiquinone oxidoreductase 30 kDa subunit 0.0030 1.38 ETC complex I
P24752 ACAT1 Acetyl-CoA acetyltransferase 9.1E-05 1.38 Ketone body metabolism
P09622 DLD Dihydrolipoyl dehydrogenase 0.0051 1.36 Gycine cleavage
Q9UJZ1 STOML2 Stomatin-like protein 2 0.0052 1.36 Receptor binding
P09972 ALDOC Fructose-bisphosphare aldolase C 0.0061 1.34 Glycolysis
P38606 ATP6V1A V-type proton ATPase catalytic subunit A 0.0067 1.33 ATP hydrolysis transport
P13804 ETFA Electron transfer flavoprotein subunit alpha 0.0005 1.33 Respiratory ETC
P30084 ECHS1 Enoyl-CoA hydratase 0.0043 1.33 Fatty acid metabolism
P40926 MDH2 Malate dehydrogenase 0.0009 1.32 Citric acid cycle
P10809 HSPD1 60 kDa heat-shock protein 0.0012 1.31 Protein folding
P62258 YWHAE 14-3-3 protein epsilon 0.0056 1.30 Apoptosis
P04181 OAT Orthinine aminotransferase 0.0012 1.30 Amino acid biosynthesis
Q13011 ECH1 Delta (3,5)-delta(2,4)-dienoyl-CoA isomerase 0.0048 1.28 Lipid metabolism
Q99714 HSD17B10 3-hydroxyacyl-CoA dehydrogenase type 2 0.0037 1.27 Lipid metabolism
P07954 FH Fumarate hydratase 0.0038 1.27 Citric acid cycle
P30044 PRDX5 Peroxiredoxin 5 0.0014 1.26 Redox homeostasis
P42765 ACAA2 3-ketoacyl-CoA thiolase 0.0067 1.26 Lipid metabolism
P25325 MPST 3-mercaptopyruvate sulfurtransferase 0.0012 1.25 Response to Toxins
P30086 PEBP1 Phosphatidylethanolamine binding protein 1 0.0067 1.24 Protease inhibition
P25705 ATP5A1 ATP synthase subunit alpha 0.0019 1.21 ETC complex V
Q06830 PRDX1 Peroxiredoxin 1 0.0009 1.20 Redox homeostasis
P43686 PSMC4 26S protease regulatory subunit 6B 0.0007 1.20 Protein degradation
Q16718 NDUFA5 NADH-ubiquinone oxidoreductase 13 kDa subunit 0.0022 1.20 ETC complex I
O00154 ACOT7 Cytosolic acyl-coenzyme A thioester hydrolase 0.0009 1.19 Acyl-CoA hydrolysis
Q00610 CLTC Clathrin heavy chain 1 4.9E-05 1.16 Endocytosis
P12277 CKB Creatine Kinase B type 0.0027 1.16 Creatine metabolism
Endoplasmic reticulum
O60568 PLOD3 Procollagen-lysine 2-oxoglutarate 5-dioxygenase 3 7.7E-05 1.87 Lysyl hydroxylation
P27797 CALR Calreticulin 1.0E-07 1.56 Protein folding
P11021 HSPA5 Heat-shock protein 5 3.9E-05 1.53 Protein complex assembly
P14625 HSP90B1 Heat-shock Protein 90 kDa beta member 1 5.5E-05 1.49 Protein transport
P30101 PDIA3 Protein disulfide isomerase A3 2.7E-05 1.45 Protein folding
Q16799 RTN1 Reticulon 1 0.0055 1.41 Neuron differentiation
Q8NBS9 TXNDC5 Thioredoxin-domain containing protein 5 0.0017 1.40 Cell redox homeostasis
P13667 PDIA4 Protein disulfide isomerase A4 1.4E-05 1.38 Cell redox homeostasis
Q9Y2B0 CNPY2 Protein canopy homolog 2 0.0051 1.38 Protein binding
Q15084 PDIA6 Protein disulfide isomerase A6 6.1E-06 1.37 Chaperone
P54920 NAPA Alpha soluble NSF attachment protein 0.0003 1.35 ER-golgi vesicle transport
P14314 PRKCSH Glucosidase 2 subunit beta 0.0016 1.33 Glycoprotein formation
Q9NQC3 RTN4 Reticulon 4 0.0033 1.32 Neurogenesis/apoptosis
Q14697 GANAB Neutral alpha-glucosidase AB/GNAB protein 0.0018 1.27 Glycoprotein cleavage
P07237 P4HB Protein disulfide isomerase 0.0073 1.25 Redox homeostasis
Q9BS26 ERP44 Endoplasmic reticulum resident protein 44 0.0007 1.23 ER stress response
Q9NYU2 UGGT1 UDP glucose:glycoprotein glucosyltransferase 1 0.0074 1.23 ER protein folding
P30040 ERP29 Endoplasmic reticulum resident protein 29 0.0003 1.23 ER protein folding
P55072 VCP Valosin-containing protein 0.0069 1.15 ER stress response
Ribosomes
P69905 HBA1 Hemoglobin subunit alpha 0.0003 1.97 O2 transport
Vesicle
O15240 VGF Neurosecretory protein VGF 0.0035 1.39 Cell–cell interactions
P08133 ANXA6 Annexin 6 0.0075 1.18 Ca2þ binding
P21281 ATP6V1B2 V-type proton ATPase subunit B 0.0098 1.16 Hþ ion transport
P07900 HSP90AA1 Heat Shock Protein HSP90-alpha 0.0030 1.11 Stress response
Q9BTT0 ANP32E Acidic leucine-rich nuclear phosphoprotein 32E 0.0034 1.08 Phosphatase inhibitor
Cytoskeleton
P52907 CAPZA1 F-actin capping protein subunit alpha 1 0.0039 1.35 Protein complex assembly
P16949 STMN1 Stathmin 0.0029 1.32 Microtubule disassembly
Q9Y230 RUVBL2 RuvB like 2 0.0037 1.31 Transcription
P47756 CAPZB F-actin-capping protein subunit beta 3.2E-05 1.25 Protein complex assembly
Q03252 LMNB2 Lamin B2 0.0076 1.24 Cytoskeleton regulation
Q16352 INA Alpha-internexin 4.9E-05 1.24 Neurogenesis
P07437 TUBB Tubulin beta chain 0.0016 1.23 Microtubule constituent
P36405 ARL3 ADP-ribosylation factor-like protein 3 0.0071 1.23 Cell division
P61163 ACTR1A Alpha centractin 0.0029 1.23 Vesicle mediated transport
Q9UJU6 DBNL Debrin-like protein 0.0095 1.18 Endocytosis
Q16658 FSCN1 Fascin 0.0018 1.18 Cytoskeleton organization
P62158 CALM Calmodulin 0.0059 1.17 Calcium modulation
Q9BZK7 TBL1XR1 F-box like/WD repeat containing protein TBL1XR1 0.0046 1.17 Protein degradation
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Table 1. (Continued )
Uniprot accn no. Gene name Protein name P value Fold change Protein function
P49773 HINT1 Histidine triad nucleotide-binding protein 1 0.0002 1.15 Signal transduction
P43487 RANBP1 Ran-specific GTPase-activating protein 0.0029 1.15 Signal transduction
Spliceosome
Q07955 SRSF1 Serine/Arginine-rich splicing factor 1 1.1E-05 1.42 mRNA splicing
Q01081 U2AF1 Splicing factor U2AF 35 kDa subunit 0.0062 1.23 mRNA splicing
Q15029 EFTUD2 116 kDa U5 small nuclear ribonucleoprotein 0.0069 1.19 mRNA splicing
Proteosome
Q15008 PSMD6 26s proteasome non ATPase regulatory subunit 6 0.0053 1.61 Protein degradation
P17980 PSMC3 26S protease regulatory subunit 6A 0.0071 1.27 Protein degradation
Q13200 PSMD2 26S proteasome non-ATPase regulatory subunit 2 0.0005 1.22 Protein degradation
P54727 RAD23B UV excision protein RAD23 homolog B 0.0009 1.22 Protein degradation
Q99460 PSMD1 26S proteasome non-ATPase regulatory subunit 1 0.0002 1.18 Protein degradation
O00231 PSMD11 26S proteasome non-ATPase regulatory subunit 11 0.0008 1.18 Protein degradation
P28066 PSMA5 Proteasome subunit alpha type 5 0.0036 1.16 Protein degradation
ER, endoplasmic reticulum; ETC, electron transport chain; OGD, oxygen glucose deprivation.
Proteins are grouped according to subcellular compartment based on gene ontology and ranked according to magnitude of fold change. The significance
threshold was set a priori at Po0.01.
Table 2. Proteins Significantly Decreased with OGD (18 hours)
Uniprot accn no. Gene name Protein name P-value Fold change Protein function
Mitochondria
P21796 VDAC1 Voltage-dependent anion selective channel protein 1 0.0079 0.26 Ion transport
P22695 UQCRC2 Cytochrome b-c1 complex subunit 2 0.0017 0.31 ETC complex III
P31930 UQCRC1 Cytochrome b-c1 complex subunit 1 0.0097 0.46 ETC complex III
Q9NS69 TOM22 Translocase of outer membrane 22 kDa subunit 0.0027 0.46 Protein transport
Q9Y3E5 BIT1 Peptidyl-tRNA hydrolase 2 0.0038 0.51 Apoptosis
P02786 TFRC Transferrin receptor protein 1 0.0002 0.58 Endocytosis
O75534 CSDE1 Cold shock domain containing protein E1 1.0E-06 0.62 Transcription
Q9Y6H1 CHCHD2 Coiled-coil helix–coiled-coil helix domain protein 2 0.0099 0.70 unknown
P11310 ACADM Medium chain specific acyl-CoA dehydrogenase 0.0084 0.79 Lipid metabolism
Endoplasmic reticulum
Q81V08 PLD3 Phospholipase D3 0.0016 0.61 Lipid degradation
Q96AG4 LRRC59 Leucine rich repeat-containing protein 59 0.0048 0.64 ER membrane interactions
P13637 ATP1A3 Naþ /Kþ ATPase alpha (III) subunit 0.0008 0.67 ATP hydrolysis catalyst
P04843 RPN1 Ribophorin 1 0.0094 0.68 Glycosyltransferase activity
Ribosomes
P63173 RPL38 60s ribosomal protein L38 0.0001 0.65 Protein biosynthesis
P62249 RPS16 40S ribosomal protein S16 7.9E-05 0.70 Protein biosynthesis
P35544 FAU Ubiquitin-like protein FUB 1 0.0012 0.70 Ubiquitination modulation
P62263 RPS14 40S ribosomal protein S14 0.0004 0.74 Protein biosynthesis
P62829 RPL23 60S ribosomal protein L23 5.3E-05 0.74 Protein biosynthesis
P62266 RPS23 40S ribosomal protein S23 0.0004 0.76 Protein biosynthesis
P46781 RPS9 40S ribosomal protein S9 0.0002 0.78 Protein biosynthesis
P08708 RPS17 40S ribosomal protein S17 0.0004 0.80 Protein biosynthesis
P42766 RPL35 60S ribosomal protein L35 0.0018 0.82 Protein biosynthesis
P26373 RPL13 60S ribosomal protein L13 0.0004 0.84 Protein biosynthesis
Vesicle
P07355 ANXA2 Annexin A2 0.0038 0.49 Ca2þ binding
P62491 RAB11A Ras-related protein Rab 11A 0.0026 0.76 Endocytic cycling
P07858 CTSB Cathepsin B 0.0053 0.85 Protein degradation
Cytoskeleton
P06493 CDK1 Cyclin-dependent kinase 1 0.0022 0.57 Cell-cycle control
P28289 TMOD1 Tropomodulin 1 0.0005 0.64 Cytoskeleton organization
Q01518 CAP1 Adenylyl cyclase-associated protein 1 4.7E-06 0.70 Signal transduction
Q9UQE7 SMC3 Structural maintenance of chromosomes protein 3 0.0084 0.71 Cell cycle
P18206 VCL Viniculin 0.0067 0.78 Cell adhesion
Q01082 SPTBN1 Spectrin beta chain brain 1 0.0092 0.81 Cytoskeleton movement
Spliceosome
P17844 DDX5 Probable ATP-dependent RNA helicase DDX5 2.9E-06 0.58 mRNA processing
Q9UKM9 RALY RNA-binding protein Raly 0.0014 0.66 mRNA splicing
Q86V81 THOC4 THO complex subunit 4 0.0007 0.75 mRNA splicing
O43143 DHX15 Pre-mRNA splicing factor ATP-dep. RNA helicase 5.5E-06 0.78 mRNA splicing
P07910 HNRNPC Heterogeneous nuclear ribonucleoproteins Ca/C2 0.0005 0.81 mRNA splicing
ER, endoplasmic reticulum; ETC, electron transport chain; OGD, oxygen glucose deprivation.
Proteins are grouped according to subcellular compartment based on gene ontology and ranked according to magnitude of fold change. The significance
threshold was set a priori at Po0.01.
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metabolic stress makes the proteomic results particularly
pertinent to mild, sustained ischemia challenges and the
compromised energy metabolism associated with slowly evolving
neurodegenerative disorders such as Alzheimer’s disease.3
Proteomics has showed alterations and interactions in mito-
chondrial, ER, and ribosomal proteins after OGD. The ETCproteins
displayed bidirectional changes (Complex I and V proteins
increased and Complex III proteins decreased) in response to
OGD. Other mitochondrial proteins involved in lipid and ketone
metabolism, including AD-related HSD17B10 (more commonly
known as ABAD), were also increased after OGD (18 hours). The ER
stress response proteins along with proteins involved in protea-
somal/ubiquitination degradation also formed an important part
of the upregulated proteomic response to the metabolic
challenge of OGD.
A signiﬁcant mitochondrial proteomic response was observed
after OGD. Two of the most markedly decreased proteins after
18 hours OGD were subunits 1 and 2 (UQCRC1 and UQCRC2) of
ETC complex III. Complex III is the third component of the ETC
located within the inner mitochondrial membrane. Complex III
mediates the transfer of electrons from ubiquinone to cytochrome
C, and in doing so translocates a proton into the inner-membrane
space and contributes to the generation of the electrochemical
gradient used for the production of ATP.19 Complex III is also
intrinsically involved in the generation of reactive oxygen species
from the mitochondria during hypoxia, and these reactive oxygen
species work to stabilize HIF1a and initiate protein transcription.20
A signiﬁcant decrease in UQCRC1 and UQCRC2 might be an
attempt by the cells to reduce the production of reactive oxygen
species from the mitochondria under stress conditions.
Interestingly, UQCRC1 has also been recorded as signiﬁcantly
decreased in the brains of AD patients.21 The similar decrease in
UQCRC1 expression observed in AD patients and cells in vitro after
OGD may provide a link between chronic oxidative challenge and
the onset and progression of AD.
The Energy Production Interactome (Figure 4B) also highlighted
putative functional protein–protein interactions between UQCRC1,
UQCRC2, and RTN4 (a protein increased after 18 hours OGD). RTN4
is increased in hippocampal neurons of AD patients22 and is
known to interact with BACE1, reducing AB40 and AB42 levels.23
The dysregulation of RTN4 after a metabolic challenge (18 hours
OGD), its interaction with complex III proteins, and its potential
role in APP processing, highlights RTN4 protein as a compelling
target for future investigation.
Mitochondrial complex I and V proteins were signiﬁcantly
increased in expression after OGD in sharp contrast to the
reduction in complex III proteins after OGD. Complex I is the ﬁrst
protein complex of the ETC and initiates the transfer of electrons
required for oxidative phosphorylation. The process is initiated
through binding and oxidation of NADH, with the concurrent
transfer of two electrons from NADH to ubiquinone, and
the translocation of four protons into the intermembrane space.24
An increase in Complex I proteins after OGD may reﬂect a
compensatory mechanism to counteract the impact of decreased
complex III proteins on energy production. Similarly, the increase
in Complex V proteins may reﬂect a compensation for
downregulated Complex III proteins or a general remodeling of
the ETC, as has previously been shown in studies investigating
ischemic preconditioning.25 Functional assays of the ﬁve
complexes that constitute the ETC, in ischemic conditions will
need to be carried out to conﬁrm whether such remodeling
occurs. Determining the regulatory mechanisms of these protein
changes could provide valuable insight that would allow
therapeutic intervention to alter the course of mitochondrial
dysfunction after OGD and metabolic challenges in vivo.
Concurrent with the dysregulation of the oxidative phosphor-
ylation pathway, OGD (18 hours) induced an increase in mito-
chondrial proteins involved in lipid and ketone metabolism.
The increase in these proteins (ACAT1 in ketone metabolism, and
ACADM, ECH1, HSD17B10, and ACAA2 in lipid metabolism)
Figure 4. Mitochondrial energy production proteins and associated interacting partners are affected by oxygen glucose deprivation (OGD).
(A) Key mitochondrial energy production proteins (UQCRC1/UQCRC2) and their putative interacting partners (RTN4/RUVBL2) are significantly
altered by OGD (18 hours). Each data point represents an independent sample with the mean abundance line shown (**Po0.01, T-test).
(B) Energy Production Interactome. One of the highest scoring Ingenuity Pathway Analysis (IPA) networks gained from the 18-hour OGD
proteomic data set is presented. The network contains numerous proteins involved in mitochondrial energy production, the colored nodes
indicate proteins detected in our study as significantly altered by OGD. Red nodes are upregulated proteins and green nodes are
downregulated. Unshaded nodes were manually inserted by IPA to augment functional coherence. Only direct protein–protein interactions
were included in the analysis.
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indicates a shift toward using lipid and ketone bodies as
alternative sources of energy for SH-SY5Y cells faced with glucose
restriction. The availability of such alternative energy sources is
likely to be important in preventing cells hitting the point where
energy provision is insufﬁcient for cell survival, leading to a
downward spiral of metabolic and cognitive decline. A recent
study using a triple transgenic model of AD showed an induction
of ketogenesis after a 2-deoxy-D-glucose diet was introduced. This
correlated with an increase in nonamyloidogenic APP processing
pathways, reduced AD pathology and reduced oxidative stress,26
indicating a potential therapeutic role for enhanced ketone
metabolism.
To use ketones as an alternative energy source in the brain,
acetoacetate and b-hydroxybutyrate (the main ketone bodies
used for energy) need to be synthesized from acetyl-coA. Acetyl-
coA is released after beta oxidation of fatty acids, a four step
process within the mitochondrial matrix requiring beta-oxidation
enzymes at each stage (namely, ACAD, ECH1, HSD17B10, and
ACAA2). Each of these beta-oxidation enzymes, as noted above,
was signiﬁcantly altered after 18 hours OGD. Of note, the third
beta-oxidative enzyme HSD17B10 (ABAD) is now emerging as an
important player in AD. ABAD has been shown to directly interact
with Ab in the mitochondria of AD patients and AD transgenic
mouse models. Inhibition of the ABAD-Ab interaction suppresses
Figure 5. Protein production, folding, and degradation pathways are affected by oxygen glucose deprivation (OGD). (A) Key proteins involved
in protein folding and the endoplasmic reticulum stress response (HSPA5/HSP90B1/PDIA3/PDIA4) are significantly altered by OGD (18 hours).
(B) Protein Folding and Degradation Interactome. A high scoring Ingenuity Pathway Analysis (IPA) network generated from the 18-hour OGD
proteomic data set contained numerous proteins involved in protein folding and degradation is presented. The colored nodes indicate
proteins detected in our study as significantly altered by OGD. Red nodes are upregulated proteins and green nodes are downregulated
proteins. Unshaded nodes were manually inserted by IPA to augment functional coherence. Only direct protein–protein interactions were
included in the analysis. (C) Representative ribosomal proteins (RPS9/RPS16) and the cellular stress response proteins (PRDX1/PRDX2) are
significantly altered by OGD (18 hours). Each data point represents an independent sample (**Po0.01, ***Po0.0001, T-test). (D) 40S
Ribosomal Interactome. A further high scoring IPA network was dominated by the downregulation of 40S ribosomal proteins and cell stress
response proteins.
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induced apoptosis by increasing levels of Ab, and conversely
overexpression of ABAD in transgenic mice with high levels of Ab
has been shown to cause heightened neuronal oxidative stress
and memory impairments.27 The direct involvement of ABAD in
AD pathophysiology makes ABAD an interesting candidate
to investigate further in terms of its upregulation upon
metabolic challenge.
Pore forming proteins VDAC1 and TOM22 were signiﬁcantly
downregulated after OGD. VDAC1 is thought to be involved in the
formation of the mPTP, which in turn allows calcium and solutes
o1.5 kDa to pass across the mitochondrial membranes, resulting
in osmotic swelling, loss of the mitochondrial membrane
potential, and damage to the electron transport respiratory
chain.28 Mitochondrial swelling after OGD was clearly showed in
the human cells under the electron microscope (Figure 2D).
The role that these mitochondrial pore forming proteins have in
mediating mitochondrial swelling after OGD needs to be deﬁned
to facilitate the discovery of novel pathways that might be
manipulated to restore mitochondrial normality.
A major proteomic response in the ER was identiﬁed after OGD.
The ER stress response (also known as the unfolded protein
response, UPR) is a cellular reaction activated to clear misfolded
proteins that accumulate upon ER stress, thus returning the cell to
a state of proteostasis.29 Two central molecular chaperones,
HSPA5 and HSP90B1, involved in the early and late stages of the
UPR respectively were upregulated after OGD in SH-SY5Y cells
(as well as numerous other UPR proteins and ER stress proteins)
(Figure 5A). These data are consistent with recent results from
OGD in mixed primary cortical cultures where increases in both
HSPA5 and HSP90B1 were detected.30 The induction of the UPR in
response to OGD was also implied in the electron microscopic
data. The ER showed a progressive morphologic swelling that
signiﬁcantly increased after longer durations of OGD exposure
compared with time-matched controls (Po0.01, Figure 2C).
An expanded ER forms an important part of the UPR as it enables
larger numbers of misfolded proteins to be incorporated within
the ER membrane, thus increasing cellular capacity to deal with
abundant protein damage.31 A larger ER volume also reduces the
concentration of protein intermediates, therefore reducing the risk
of protein aggregate formation.32 The morphologic observation of
enlarged ER along with the signiﬁcant increase in UPR proteins
HSPA5 and HSP90B1 detected in our proteomic data provides
telling insights into how the human neuronal cells respond to the
metabolic challenge of OGD.
In accord with activation of the UPR, an upregulation of
numerous proteins involved in proteasomal degradation was
highlighted by the Protein Folding and Degradation Interactome.
Subunits of the 20S and 19S (core and regulatory) particles that
constitute the 26S proteasome were increased, suggesting
26S proteasomal degradation to be a fundamental mechanism
for degrading the misfolded proteins that accumulate in response
to metabolic challenge. There has been a long-standing
hypothesis that protein aggregates in diseased brain impair the
protein degradation function of the 26S proteasome.33–35 Our
proteomic data show proteasomal proteins to be upregulated
after a metabolic challenge. It is therefore possible to hypothesize
that any proteasomal response to metabolic challenge might be
adversely affected in the presence of protein aggregates
associated with neurodegenerative diseases such as AD. In this
situation, the cellular capacity to cope with metabolic stress
would be impaired, potentially leading to a deterioration in
cellular function.
A coordinated response after OGD (18 hours) was also observed
in the ribosomal proteome. Numerous ribosomal proteins that
constitute the core ribosomal machinery were downregulated,
and in line with this, several eukaryotic initiation factors central to
protein synthesis were also decreased. It is well established
that cells undergoing severe metabolic stress experience a
downregulation of protein translation, which can be reversible
in more resistant brain areas, and irreversible in vulnerable
regions.36 Further work involving a recovery phase would need to
be undertaken to understand whether the decrease in protein
synthesis machinery is a survival mechanism to conserve energy,
or whether it ultimately pushes the cells down a cell death route.
The proteomic data does suggest that activation of the UPR
correlates with a decrease in global protein synthesis, perhaps to
deal with the accumulation of misfolded proteins.37
Substrate deprivation both in vivo and in vitro has long been
recognized to evoke a marked genomic response. Whether this
genomic response translates into distinct alterations in protein
expression has been a matter of debate. The present study clearly
shows the considerable adaptive capacity of the SH-SY5Y
proteome to a prolonged metabolic challenge in vitro, but caution
must be exercised in the extrapolation of the present data to
cerebral ischemia in vivo. No single cell culture system can model
the complexity of the response of cerebral tissue to substrate
deprivation. Astrocyte cultures and neuronal cells of neuroblas-
toma lineage (such as SH-SY5Y cells) can tolerate prolonged OGD,
whereas primary neuronal and oligodendrocyte cultures are
irreversibly damaged within a few hours.38,39 The temporal
susceptibility of these different cultures to metabolic challenge,
their ability to generate energy from various sources (SH-SY5Y
cells have considerable capacity to perform anaerobic glycolysis40)
and their intrinsic energy demands will all impact on the evoked
proteomic response to OGD.
Additional proteomic and biochemical analyses (not just LC-MS
as in the present study) including protein–protein interaction
assays, membrane potential recordings, and in vitro ATP levels
across a range of different cell types would enhance our
understanding of the true nature of the metabolic challenge
posed by OGD. These studies would also provide more detail as to
the subtleties of the proteomic changes, not only in terms of
abundance, but also in cellular and subcellular localization, and
the interacting partners of altered proteins.
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